February 2021
SAFETY OBSERVER N175
16 PAGES
Draft GVP Module XVI on RMMs
EMA CTIS Training
Post-Brexit Guidance
Canada ADR Reporting guidance
And more...
PUBLICATIONS / NUMBER 175
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Latest ReleaseSafety Observer 179EMA Training on CTIS
Canada & Combination Products
New PV Guidance in South Africa
And more...
Safety Observer 178Draft ICH E6(R3) Principles
New MedDRA Mappings
ABPI updates Guidance
FDA Regulatory Action
COVID-19 Vaccines & Safety
Safety Observer 177EU Clinical Trial Regulation
FDA and E2B requirements
Health Canada & ePI
COVID-19 Vaccines & Safety
Servier and Mediator
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
